why you still feel terrible despite normal tests

Why Your Doctor Says You’re ‘Fine’ — But You Still Feel Terrible

Author: Rohan Smith | Functional Medicine Practitioner | Adelaide, SA

Quick Answer

Why you still feel terrible despite normal tests is one of the most common frustrations in clinical care today. Many people continue to experience fatigue, brain fog, pain, sleep issues, digestive symptoms, or mood imbalances even after being told their blood work is “normal.” Standard panels like TSH, cholesterol, or basic hormone tests may not capture underlying metabolic dysfunction, nutrient imbalances, immune dysregulation, or chronic inflammation — all of which can affect how you feel regardless of how the numbers look. In this article, we explore common hidden factors that contribute to persistent symptoms and why traditional testing may not tell the full story.

The Core Problem: “Normal” Does Not Mean Optimal

Many people feel dismissed after repeated medical visits where test results are reported as normal despite ongoing symptoms. This disconnect is common and typically reflects a limitation of reference ranges rather than imaginary or psychological causes.

Laboratory reference ranges are usually calculated using population averages that include both healthy individuals and those with early or subclinical disease (1). Falling within that range simply means overt disease has not been detected — not that physiology is functioning at an optimal level.

Example: Thyroid Function

Thyroid-stimulating hormone (TSH) is often used as the sole marker of thyroid health. While many laboratories define normal TSH as up to 4.0–5.0 mIU/L, multiple studies suggest that symptom-free individuals tend to cluster between approximately 1.0–2.0 mIU/L (2–4).

A TSH of 3.5 mIU/L may therefore be labelled “normal” yet still be associated with fatigue, cold intolerance, weight gain, or cognitive slowing — a pattern often referred to as subclinical thyroid dysfunction (5).

What Standard Testing Commonly Misses

Typical GP blood panels assess around 10–15 markers and are primarily designed to screen for organ failure or advanced disease rather than functional efficiency. Several key physiological systems are often under-investigated, including:

  • Gastrointestinal and microbiome health
  • Stress-hormone rhythm and signalling
  • Nutrient-dependent metabolic pathways
  • Neuroimmune and inflammatory regulation

Gut Health

The gut microbiome plays a central role in immune regulation, nutrient absorption, and neurotransmitter signalling. Approximately 90% of serotonin is produced in the gastrointestinal tract, influencing mood, sleep, and stress tolerance (6–8). Gut microbiome imbalance and intestinal inflammation are not detected through routine blood testing.

Cortisol Rhythm

Cortisol is a stress hormone with a diurnal (daily) rhythm, normally peaking in the morning and gradually declining toward night. Disruption of this rhythm has been associated with fatigue, sleep disturbance, mood changes, and reduced stress resilience (9,10). Single serum cortisol measurements do not capture this dynamic pattern.

Methylation Pathways

Methylation refers to a group of biochemical reactions involved in detoxification, neurotransmitter metabolism, DNA regulation, and hormone clearance. Methylation pathways may function inefficiently in some individuals, contributing to fatigue, poor stress tolerance, and hormonal symptoms, yet they are not directly assessed in standard pathology testing (11,12).

The Functional Medicine Difference

Functional medicine testing aims to assess how well systems are functioning, rather than simply determining whether disease is present.

  • DUTCH hormone testing evaluates hormone metabolites and cortisol rhythm instead of relying on single static values, offering insight into hormone processing and stress physiology (13).
  • Organic Acids Testing (OAT) can identify functional nutrient deficiencies, mitochondrial energy markers, neurotransmitter metabolites, and microbial by-products that are not visible on standard blood work (14–16).
  • Comprehensive stool and microbiome testing can assess digestion, inflammation, microbial balance, and immune signalling within the gut (17).

These tools are not used in isolation to diagnose disease, but to identify patterns of dysfunction that may help explain persistent or unexplained symptoms.

Interpreting Existing Blood Tests Differently

In many cases, valuable information already exists within previous GP-ordered tests — it has simply not been interpreted through an optimal-range or systems-based lens.

  • Ferritin around 30 µg/L — technically normal, yet frequently associated with fatigue, hair loss, and impaired thyroid function (18–20).
  • Mildly elevated liver enzymes — which may reflect oxidative stress or metabolic burden rather than overt liver disease (21).
  • Cholesterol patterns — which can provide insight into inflammation or thyroid status, not just cardiovascular risk (22).

For this reason, reviewing prior pathology is often the most efficient starting point before deciding whether additional investigations are warranted.

Frequently Asked Questions

If my blood tests are normal, could my symptoms still be physiological?

Yes. Standard blood tests are designed to detect overt disease rather than early, functional, or system-level dysfunction. Many physiological imbalances — including disrupted stress-hormone signalling, gut–immune interactions, nutrient insufficiencies, and inflammatory load — can affect how you feel without pushing markers outside laboratory reference ranges.

Does this mean my symptoms are “all in my head”?

No. Persistent symptoms with normal test results are rarely psychological in origin alone. Research shows that subclinical metabolic, immune, and neuroendocrine patterns can produce real, measurable symptoms even when conventional pathology appears unremarkable. The issue is often incomplete testing or interpretation, not imagined illness.

Should I repeat standard blood tests or look at them differently?

In many cases, reviewing existing blood work through an optimal-range and systems-based lens is more informative than repeating the same tests. Markers such as ferritin, thyroid indices, liver enzymes, and lipid patterns can provide valuable insight when interpreted in context with symptoms, lifestyle, and stress physiology.

What Happens Next

When underlying contributors are identified, care can move away from trial-and-error symptom management toward targeted, physiology-driven intervention. This may include nutritional repletion, gut-focused strategies, stress-hormone support, or lifestyle adjustments guided by objective data.

For many patients, this process also provides clarity and reassurance. Persistent symptoms are not a personal failing — they are often the result of measurable physiological patterns that have not yet been addressed.

Your Next Step

If you’ve been told you’re “fine” but continue to feel unwell, a deeper evaluation may be appropriate. A brief discovery call can help determine whether reviewing existing results or exploring functional investigations makes sense for your situation.

Feeling “fine” is not the same as functioning well — and understanding that distinction is often the first meaningful step forward.

Book a free 15min Discovery Call

REFERENCES

  1. Katayev A, et al. Clin Chim Acta. 2010. 
  2. Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab. 2005 Sep;90(9):5483-8. doi: 10.1210/jc.2005-0455. https://doi.org/10.1210/jc.2005-0455
  3. Andersen S, et al. Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab. 2002 Mar;87(3):1068-72. doi: 10.1210/jc.87.3.1068. https://doi.org/10.1210/jc.87.3.1068
  4. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008 Feb;29(1):76-131. doi: 10.1210/er.2006-0043.  https://doi.org/10.1210/er.2006-0043
  5. Peeters RP. Subclinical Hypothyroidism. N Engl J Med. 2017 Apr 27;376(17):e36. https://doi.org/10.1056/NEJMcp1611144
  6. Gershon MD. The enteric nervous system: a second brain. Hosp Pract (1995). 1999 Jul 15;34(7):31-2, 35-8, 41-2 passim. 
  7. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012 Oct;13(10):701-12. doi: 10.1038/nrn3346. https://doi.org/10.1038/nrn3346
  8. Yano JM, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015 Apr 9;161(2):264-76. doi: 10.1016/j.cell.2015.02.047. https://doi.org/10.1016/j.cell.2015.02.047
  9. Adam EK, et al. Diurnal cortisol slopes and mental and physical health outcomes: A systematic review and meta-analysis. Psychoneuroendocrinology. 2017 Sep;83:25-41. doi: 10.1016/j.psyneuen.2017.05.018. https://doi.org/10.1016/j.psyneuen.2017.05.018
  10. Fries E, et al. A new view on hypocortisolism. Psychoneuroendocrinology. 2005 Oct;30(9):1010-6. 
  11. Stover PJ. One-carbon metabolism in health and disease. Am J Clin Nutr. 2009 Mar;89(3):1033S-1038S. doi: 10.3945/ajcn.2008.27493C. 
  12. Crider KS, et al. Prenatal folic acid supplementation and risk of congenital heart defects. Am J Clin Nutr. 2012 Jul;96(1):114-22. 
  13. Newman MS, et al. Steroid hormone analysis by tandem mass spectrometry in clinical laboratories. J Steroid Biochem Mol Biol. 2020 Jan;196:105501. 
  14. Lord RS, et al. Organic acids: a new tool for functional assessment. Altern Med Rev. 2008 Sep;13(3):216-28.
  15. Lambrecht NJ, et al. Biochemical markers of bone turnover. Clin Biochem. 2012;45(13-14):1063-71. 
  16. Sweetman L. Organic acid analysis. J Inherit Metab Dis. 2013;36(3):513-20.
  17. Vipperla K, O’Keefe SJ. The microbiota and its metabolites in colonic diseases. Clin Gastroenterol Hepatol. 2016;14(12):1686-92. 
  18. Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015 Feb 19;372(8):783-92. doi: 10.1056/NEJMra1401038. https://doi.org/10.1056/NEJMra1401038
  19. Beard JL. Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr. 2001 Feb;131(2S-2):568S-579S. doi: 10.1093/jn/131.2.568S. https://doi.org/10.1093/jn/131.2.568S
  20. Zimmermann MB, et al. Iodine deficiency disorders. Thyroid. 2008;18(12):1269-77. 
  21. Sanyal AJ. Nonalcoholic fatty liver disease. Hepatology. 2011;54(5):1845-55. 
  22. Duntas LH. Thyroid function in obesity. Thyroid. 2002;12(10):879-83.